NDC 13668-0339-30
Lamotrigine 25 mg/1 TABLET, EXTENDED RELEASE
Available — 2-Day Shipping
NDC
13668-0339-30
Generic Name
Lamotrigine
Brand Name
Lamotrigine
Strength
25 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Package Size
—
Labeler
Torrent Pharmaceuticals Limited
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Lamotrigine extended-release tablets are indicated for: adjunctive therapy for primary generalized tonic-clonic seizures (PGTC) and partial-onset seizures with or without secondary generalization in patients aged 13 years and older. ( 1.1 ) conversion to monotherapy in patients aged 13 years and older with partial-onset seizures who are receiving treatment with a single antiepileptic drug (AED). ( 1.2 ) Limitation of use: Safety and effectiveness in patients younger than…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Lamotrigine Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Lamotrigine NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 13668-0339-30 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).